Lilly Posted July 25, 2026

Director, Global Regulatory Affairs – Chemistry, Manufacturing and Controls (CMC), Platform Innovation – Synthetic Peptides and Oligonucleotides

Indianapolis, Indiana, United States of America FULL_TIME
Manufacturing & CMC Director

Lilly is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work, but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

This role provides strategic, tactical, and operational regulatory CMC leadership across advanced therapeutic modalities and manufacturing technologies to accelerate development of the synthetic peptides and oligonucleotide portfolio, supporting clinical trial applications, market registrations, and post-approval submissions. This is accomplished through a strong working knowledge of global regulations, guidelines, and regulatory precedent, coupled with deep technical expertise in CMC development and manufacturing processes specific to synthetic peptides and oligonucleotides.

Key Responsibilities

Deep technical knowledge of synthetic peptide and oligonucleotide CMC drug development and manufacturing sciences across modalities and platforms, including drug substance, drug product, and analytical sciences (e.g., solid-phase synthesis, purification, conjugation, characterization, and control strategies).

Knowledge of global CMC regulatory requirements and guidelines for synthetic peptides and oligonucleotides to support clinical development, global product registrations, and lifecycle management of approved products.

Development and implementation of innovative regulatory strategies and platform-based approaches, incorporating evolving external expectations (e.g., emerging guidance, novel modality considerations, and regulatory precedent).

Provide regulatory guidance enabling CMC development teams to make well-informed decisions on development strategies and lifecycle planning.

Lead preparation, critical review, and approval of CMC documentation for global regulatory submissions and responses, including clinical trial applications, marketing applications, variations/supplements, and responses to health authority queries.

Take a proactive leadership role in the critical review of molecule-specific CMC development and lifecycle strategies, including considerations unique to peptides and oligonucleotides (e.g., impurity profiles, sequence-related variants, delivery systems, and stability).

Provide high-quality, timely, and clear regulatory advice to support project teams in advancing complex modalities.

Make decisions on CMC regulatory strategies impacting global submissions, ensuring alignment across geographies, teams, and platform approaches.

Basic Qualifications/Requirements

B.S. degree in a science, engineering, or related STEM field (advanced degree preferred), such as Chemistry, Pharmaceutics, Chemical Engineering, Analytical Sciences, Biochemistry, Molecular Biology, or similar.

10+ years of Regulatory CMC or technical CMC experience supporting clinical development and/or commercialization of synthetic peptides, oligonucleotides, or related complex modalities. Candidates with broader experience in advanced modalities are encouraged to apply.

Additional Skills/Preferences

Experience authoring CMC submission content for peptides and/or oligonucleotides, including participation in clinical trial and marketing authorization applications and responses to regulatory questions.

Knowledge of major global regulatory procedures, regulations, and evolving expectations for complex modalities, including platform technologies.

Relevant experience in peptide and/or oligonucleotide drug substance and/or drug product development, manufacturing, and commercialization.

Demonstrated understanding of key development considerations for peptides and oligonucleotides (e.g., synthesis scalability, impurity control, analytical characterization, stability, and delivery systems such as conjugates or lipid-based formulations).

Extensive regulatory experience managing complex submission strategies or equivalent combination of technical and regulatory expertise.

Experience planning for and participating in Health Authority interactions.

Demonstrated ability to assess and manage risk in a highly regulated and evolving modality space.

Strong written, verbal, and presentation communication skills.

Demonstrated leadership, with strong influencing and negotiation skills.

High attention to detail and commitment to quality.

Strong collaboration skills with ability to work effectively across diverse, cross-functional teams.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form ( https://careers.lilly.com/us/en/workplace-accommodation ) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL).

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location.  The anticipated wage for this position is

$148,500 - $257,400

Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly

Job details

Seniority
Director
Function
Manufacturing & CMC
Therapeutic area
Not listed
Location
Indianapolis, Indiana, United States of America
Employment type
FULL_TIME

How this role compares

Computed from every other active Manufacturing & CMC role in our database, not just this employer's listings.

We currently track 163 comparable Director Manufacturing & CMC roles across 25 biopharma companies.

163Comparable roles tracked
157Currently active
25Companies hiring similar roles
11Countries represented

Salary context

118 of 163 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject $148,500/yr – $257,400/yr
Lowest disclosed · Senior/Principal Scientist, Bioprocess Purification Development · Lilly $79,500/yr – $116,600/yr
Highest disclosed · Sr Director Operations · Hospira, Inc. $214,900/yr – $358,100/yr
Peer group range $98,050 – $286,500 (median $184,900)

Where these roles are based

Top locations among the 163 comparable roles

United States139
India11
Netherlands4
Ireland2
France1
United Kingdom1

+ 5 more countries

Seniority mix

163 of 163 peers have a known seniority level

Principal79
Director63
Senior Director21

Therapeutic area mix

2 of 163 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology1
Vaccines & Infectious Disease1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
AstraZeneca Cambridge, Massachusetts, United States of America Director
Same function Same seniority Same country
60%similar
Lilly Indianapolis, Indiana, United States of America Director
Same function Same seniority Same country
60%similar
Lilly Indianapolis, Indiana, United States of America Director
Same function Same seniority Same country
60%similar
Lilly Indianapolis, Indiana, United States of America Director
Same function Same seniority Same country
60%similar
Lilly Indianapolis, Indiana, United States of America Director
Same function Same seniority Same country
60%similar
Lilly Indianapolis, Indiana, United States of America Director
Same function Same seniority Same country

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
Director, Integrated Bioanalysis Oncology Development
AstraZeneca · Cambridge, Massachusetts, United States of America · Director
Function Therapeutic area Seniority Country
60%
Director, Analytical Chemistry – Genetic Medicines; Analytical Development - BR&D
Lilly · Indianapolis, Indiana, United States of America · Director
Function Therapeutic area Seniority Country
60%
Director, Global Regulatory Affairs - Chemistry, Manufacturing and Controls (CMC), Platform Innovation - Small Molecules
Lilly · Indianapolis, Indiana, United States of America · Director
Function Therapeutic area Seniority Country
60%
Director of RA CMC Knowledge Management & Strategy
AbbVie · North Chicago, IL · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.